# QST-Pupillometry in Sickle Cell Disease Patients

> **NCT02242058** · — · COMPLETED · sponsor: **Julia Finkel** · enrollment: 96 (actual)

## Conditions studied

- SCD With Severe Phenotype (HbSS, HbSβ0 Thalassemia, HbSOARab)

## Interventions

- **OTHER:** Quantitative sensory testing

## Key facts

- **NCT ID:** NCT02242058
- **Lead sponsor:** Julia Finkel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2020-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242058, "QST-Pupillometry in Sickle Cell Disease Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02242058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*